Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
40
HKPD Quote, Financials, Valuation and Earnings
Last price:
$1.26
Seasonality move
:
--
Day range:
$1.20 - $1.39
52-week range:
$1.04 - $3.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
60.4K
Avg. volume:
91.4K
1-year change:
--
Market cap:
$13.6M
Revenue:
$16.7M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Hong Kong Pharma Digital Technology Holdings has -- downside to fair value with a price target of -- per share.
HKPD vs. S&P 500
-
Over the past 5 trading days, Hong Kong Pharma Digital Technology Holdings has overperformed the S&P 500 by 6.36% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Hong Kong Pharma Digital Technology Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hong Kong Pharma Digital Technology Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Hong Kong Pharma Digital Technology Holdings reported revenues of --.
Earnings Growth
-
Hong Kong Pharma Digital Technology Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Hong Kong Pharma Digital Technology Holdings reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-22 | 2024-03-22 | 2024-03-22 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-22 | 2022-03-22 | 2023-03-22 | 2024-03-22 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-22 | 2024-03-22 | 2024-03-22 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
HKPD
Sector
Market Cap
$13.6M
--
Price % of 52-Week High
32.72%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1.23
200-day SMA
Buy
Level
$0.00
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
-6.3M
20-day SMA
Sell
Level
$1.41
Relative Strength Index (RSI14)
Sell
Level
36.88
ADX Line
Sell
Level
35.83
Williams %R
Neutral
Level
-66.6667
50-day SMA
Buy
Level
$0.00
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Sell
Level
-7.6M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China’s OTC pharmaceutical cross-border e-commerce market.
Stock Forecast FAQ
In the current month, HKPD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HKPD average analyst price target in the past 3 months is --.
-
Where Will Hong Kong Pharma Digital Technology Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hong Kong Pharma Digital Technology Holdings share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hong Kong Pharma Digital Technology Holdings?
Analysts are divided on their view about Hong Kong Pharma Digital Technology Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hong Kong Pharma Digital Technology Holdings is a Sell and believe this share price will rise from its current level to --.
-
What Is Hong Kong Pharma Digital Technology Holdings's Price Target?
The price target for Hong Kong Pharma Digital Technology Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HKPD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hong Kong Pharma Digital Technology Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HKPD?
You can purchase shares of Hong Kong Pharma Digital Technology Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hong Kong Pharma Digital Technology Holdings shares.
-
What Is The Hong Kong Pharma Digital Technology Holdings Share Price Today?
Hong Kong Pharma Digital Technology Holdings was last trading at $1.26 per share. This represents the most recent stock quote for Hong Kong Pharma Digital Technology Holdings. Yesterday, Hong Kong Pharma Digital Technology Holdings closed at $1.24 per share.
-
How To Buy Hong Kong Pharma Digital Technology Holdings Stock Online?
In order to purchase Hong Kong Pharma Digital Technology Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
